Abstract:Next generation sequencing (NGS) has provided biologists with an unprecedented view into biological processes and their regulation over the past 2 decades, fueling a wave of development of high throughput methods based on short read DNA and RNA sequencing. For nucleic acid modifications, NGS has been coupled with immunoprecipitation, chemical treatment, enzymatic treatment, and/or the use of reverse transcriptase enzymes with fortuitous activities to enrich for and to identify covalent modifications of RNA and DNA. However, the majority of nucleic acid modifications lack commercial monoclonal antibodies, and mapping techniques that rely on chemical or enzymatic treatments to manipulate modification signatures add additional technical complexities to library preparation. Moreover, such approaches tend to be specific to a single class of RNA or DNA modification, and generate only indirect readouts of modification status. Third generation sequencing technologies such as the commercially available "long read" platforms from Pacific Biosciences and Oxford Nanopore Technologies are an attractive alternative for high throughput detection of nucleic acid modifications. While the former can indirectly sense modified nucleotides through changes in the kinetics of reverse transcription reactions, nanopore sequencing can in principle directly detect any nucleic acid modification that produces a signal distortion as the nucleic acid passes through a nanopore sensor embedded within a charged membrane. To date, more than a dozen endogenous DNA and RNA modifications have been interrogated by nanopore sequencing, as well as a number of synthetic nucleic acid modifications used in metabolic labeling, structure probing, and other emerging applications. This review is intended to introduce the reader to nanopore sequencing and key principles underlying its use in direct detection of nucleic acid modifications in unamplified DNA or RNA samples, and outline current approaches for detecting and quantifying nucleic acid modifications by nanopore sequencing. As this technology matures, we anticipate advances in both sequencing chemistry and analysis methods will lead to rapid improvements in the identification and quantification of these epigenetic marks.

Mass Spectrometry-Based Nucleic Acid Modifications Analysis

Deciphering nucleic acid modifications by chemical derivatization-mass spectrometry analysis

Mass Spectrometry Analysis of Nucleic Acid Modifications: from Beginning to Future.

Analysis of Nucleic Acid Modifications in Biological and Clinical Samples Based on Chemical Derivatization-Mass Spectrometry

DNA Assay Based on Monolayer-Barcoded Nanoparticles for Mass Spectrometry in Combination with Magnetic Microprobes.

Analytical Methods for Locating Modifications in Nucleic Acids

Homogeneous Detection Of Dna Sequences Based On Mass Spectrometry In Combination With Nanoparticles Probe

Qualitative and Quantitative Analytical Techniques of Nucleic Acid Modification Based on Mass Spectrometry for Biomarker Discovery

Determining RNA Natural Modifications and Nucleoside Analog-Labeled Sites by a Chemical/Enzyme-Induced Base Mutation Principle

Progress and Trends on the Analysis of Nucleic Acid and Its Modification.

Progress and trends on the analysis of nucleic acid and its modification

Quantification and Mapping of DNA Modifications.

Discovery and Accurate Detection of Rare Nucleic Acid Modifications

SWAMNA: a comprehensive platform for analysis of nucleic acid modifications

Assessment of DNA Epigenetic Modifications

A General LC-MS-based RNA Sequencing Method for Direct Analysis of Multiple-Base Modifications in RNA Mixtures.

Modification mapping by nanopore sequencing

Quantification and Mapping of RNA Modifications

Direct, Quantitative, and Base‐Resolution Sequencing of DNA and RNA Modifications

Analytical Methods for Deciphering RNA Modifications.

Applications of Nanopore Sequencing Technology in the Detection of Nucleic Acid Modifications